ESLA

NASD Estrella Immunopharma, Inc.
Oct 10, 2026 · 10:41 PM ET EOD Market Closed

$0.4100 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.4100, $0.0326 below the day’s high of $0.4426

YTD change
-73.72%
vs 20-day SMA
-18.16%
vs 200-day SMA
-60.99%

Price ranges

Previous day
$0.3083 $0.4426
open $0.3530 close $0.4100
+$0.0570 (+16.15%)
Today
$0.3083 $0.4426
$0.4100
Past week
$0.3611 $0.5055
from $0.4750 now $0.4100
-$0.0650 (-13.68%)
Past month
$0.3611 $0.7298
from $0.6730 now $0.4100
-$0.2630 (-39.08%)
This year
$0.3083 $2.1000
from $1.5600 now $0.4100
-$1.1500 (-73.72%)

Price & Performance

-1.43 (-77.72%) / 6M

$0.2924$0.8608$1.43$2.00Apr 10Jul 13Oct 9

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 92.7% away from all-time highs of $5.6200
  • ESLA is down 74% since the beginning of the year
  • ESLA is down 67% over the past 12 months
  • ESLA is down 39% over the past 1 month
  • 1% of all ESLA investors are betting against ESLA

ESLA reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -68.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.05
Earnings momentum +37.5% Quarterly EPS growth
Quarterly change +37.5%

Valuation

P/E ratio N/A
Enterprise value $17.8M
Beta 2.76

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$146.7K
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Market cap $17.8M

Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.

Competitor comparison

No peer group available for this symbol.

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.